Teicoplanin ( DrugBank: Teicoplanin )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
70	Spinal stenosis	1
299	Cystic fibrosis	1

70. Spinal stenosis

---

Clinical trials : 95 /  Drugs : 169 - (DrugBank : 61) / Drug target genes : 68 - Drug target pathways : 90

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04341831 (ClinicalTrials.gov)	April 15, 2020	8/4/2020	Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection	Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection	Lumbar Spinal Stenosis;Lumbar Disc Herniation;Scoliosis Lumbar Region;Lumbar Spondylolisthesis;Lumbar Disc Lesion	Drug: Teicoplanin	Bezmialem Vakif University	NULL	Not yet recruiting	18 Years	N/A	All	120	Phase 3	NULL

299. Cystic fibrosis

---

Clinical trials : 1,695 /  Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04176328 (ClinicalTrials.gov)	October 25, 2019	8/11/2019	Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients	An Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients	Cystic Fibrosis	Drug: Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.	Neupharma Srl	Sintesi Research Srl;Aptuit Srl;Pari Pharma GmbH	Completed	18 Years	N/A	All	12	Phase 1	Italy